NAD+ Australia

NAD+ Australia. NAD+ (nicotinamide adenine dinucleotide) is a flagship cellular- cofactor research compound studied across the longevity, mitochondrial-NAD+ and cellular-ageing research literature. The Elite AU Peptides NAD+ is independently HPLC-tested by Janoshik; the certificate of analysis is published on this page and in the lab-reports library, with the measured number and an independently verifiable Janoshik key.

Available in 100 mg and 500 mg lyophilised vials, AU-domestic, AUD pricing. The 500 mg vial is the larger-batch research workhorse most-cited across published protocols; the 100 mg vial is the lower-volume entry strength. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, not TGA-approved.

NAD+ (CAS 53-84-9; molecular formula C21H27N7O14P2, average molecular weight ≈ 663 g/mol) is nicotinamide adenine dinucleotide — a coenzyme present in every living cell. Although catalogued here alongside the research peptides, NAD+ is technically a dinucleotide (so it carries no amino-acid sequence), studied as a central cofactor in cellular redox biology, sirtuin-enzyme research and broader cellular-ageing pathways.

Its role linking cellular metabolism, sirtuin and PARP activity, and age-related decline is surveyed authoritatively by Verdin (Science, 2015). The biosynthesis and salvage pathways, and the mechanistic basis by which NAD+ precursors modulate sirtuin-dependent metabolic and mitochondrial function, are reviewed by Rajman and colleagues (Cell Metabolism, 2018).

In pathway research NAD+ is referenced as a cofactor for the sirtuin (SIRT1, SIRT3 and related) enzymes and for PARP enzymes, converging with mitochondrial-NAD+, cellular-ageing and metabolic-stress research literature. It is the most-referenced cellular-cofactor research compound in the longevity strand.

Within the catalogue NAD+ is most-cited in the longevity category alongside MOTS-c (a mitochondrial- derived peptide) and SS-31 (a mitochondrial-membrane-targeting tetrapeptide); researchers frequently compare these mitochondrial- and cofactor-research tools within the same protocol.

The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, therapeutic, anti-ageing, longevity, or human-use claim about this product. NAD+ is not TGA-approved, is not a therapeutic good, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for cofactor data and protocol-specific reference values.

Reconstitute the lyophilised NAD+ vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently rather than shaking. The required volume depends on the protocol’s downstream assay requirements — a 100 mg vial reconstituted in 5 mL of bacteriostatic water yields a 20 mg/mL working stock; a 500 mg vial reconstituted in 10 mL yields a 50 mg/mL working stock. Adjust per protocol.

Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. NAD+ is light-sensitive — research protocols typically note the light-protection step explicitly. Tamper-evident packaging; the batch label is the canonical reference for the certificate of analysis published in the lab-reports library.

Shop bacteriostatic water

Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.

30-day returns on unused product in original packaging, with prior approval.